OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting the epigenetic regulation of antitumour immunity
Simon J. Hogg, Paul A. Beavis, Mark A. Dawson, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 11, pp. 776-800
Closed Access | Times Cited: 427
Simon J. Hogg, Paul A. Beavis, Mark A. Dawson, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 11, pp. 776-800
Closed Access | Times Cited: 427
Showing 1-25 of 427 citing articles:
The language of chromatin modification in human cancers
Shuai Zhao, C. David Allis, Gang Greg Wang
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 413-430
Open Access | Times Cited: 271
Shuai Zhao, C. David Allis, Gang Greg Wang
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 413-430
Open Access | Times Cited: 271
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 165
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 165
Emerging role of natural products in cancer immunotherapy
Songtao Dong, Xiangnan Guo, Fei Han, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1163-1185
Open Access | Times Cited: 154
Songtao Dong, Xiangnan Guo, Fei Han, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1163-1185
Open Access | Times Cited: 154
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Yanlin Wu, Zhengjun Lin, Changchun Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 152
Yanlin Wu, Zhengjun Lin, Changchun Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 152
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
Yang Yang, Shuo Li, Yujiao Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 128
Yang Yang, Shuo Li, Yujiao Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 128
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition
Simon J. Hogg, Olga Motorna, Leonie A. Cluse, et al.
Molecular Cell (2021) Vol. 81, Iss. 10, pp. 2183-2200.e13
Open Access | Times Cited: 99
Simon J. Hogg, Olga Motorna, Leonie A. Cluse, et al.
Molecular Cell (2021) Vol. 81, Iss. 10, pp. 2183-2200.e13
Open Access | Times Cited: 99
Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation
Xuezhen Zeng, Guanrui Liao, Shumin Li, et al.
Hepatology (2022) Vol. 77, Iss. 4, pp. 1122-1138
Closed Access | Times Cited: 87
Xuezhen Zeng, Guanrui Liao, Shumin Li, et al.
Hepatology (2022) Vol. 77, Iss. 4, pp. 1122-1138
Closed Access | Times Cited: 87
Small molecule inhibitors targeting the cancers
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 79
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 79
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
Xuemeng Xu, Peng Qiu, Xianjie Jiang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1357-1370
Open Access | Times Cited: 74
Xuemeng Xu, Peng Qiu, Xianjie Jiang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1357-1370
Open Access | Times Cited: 74
Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets
Feng Shu, Xiao Han, Qiu-Nuo Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Feng Shu, Xiao Han, Qiu-Nuo Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 56
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 56
Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion
Elena Battistello, Kimberlee A. Hixon, Dawn E. Comstock, et al.
Molecular Cell (2023) Vol. 83, Iss. 8, pp. 1216-1236.e12
Open Access | Times Cited: 39
Elena Battistello, Kimberlee A. Hixon, Dawn E. Comstock, et al.
Molecular Cell (2023) Vol. 83, Iss. 8, pp. 1216-1236.e12
Open Access | Times Cited: 39
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 38
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 38
Epigenetic Regulation in Breast Cancer: Insights on Epidrugs
Ayoung Kim, Kyumin Mo, Hyeonseok Kwon, et al.
Epigenomes (2023) Vol. 7, Iss. 1, pp. 6-6
Open Access | Times Cited: 37
Ayoung Kim, Kyumin Mo, Hyeonseok Kwon, et al.
Epigenomes (2023) Vol. 7, Iss. 1, pp. 6-6
Open Access | Times Cited: 37
Biomedical application of metal-organic frameworks (MOFs) in cancer therapy: Stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosis
Beixu Li, Milad Ashrafizadeh, Taiwei Jiao
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129391-129391
Closed Access | Times Cited: 36
Beixu Li, Milad Ashrafizadeh, Taiwei Jiao
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129391-129391
Closed Access | Times Cited: 36
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 23
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 23
Nanomedomics
Ganghao Liang, Wanqing Cao, Dongsheng Tang, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 10979-11024
Closed Access | Times Cited: 20
Ganghao Liang, Wanqing Cao, Dongsheng Tang, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 10979-11024
Closed Access | Times Cited: 20
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 18
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 18
Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis
Shimeng Zhou, Junlan Liu, Andi Wan, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Shimeng Zhou, Junlan Liu, Andi Wan, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 16
tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application
Manli Zhou, Xiaoyun He, Jing Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Manli Zhou, Xiaoyun He, Jing Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K/AKT/HIF-1α signal pathway in endometrial carcinoma
Sitian Wei, Jun Zhang, Rong Zhao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 14
Sitian Wei, Jun Zhang, Rong Zhao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 14
Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 13
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 13
Inhibition of METTL3 Alleviates NLRP3 Inflammasome Activation via Increasing Ubiquitination of NEK7
Xinyi Zhou, Xiaoyu Yang, Shenzhen Huang, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 12
Xinyi Zhou, Xiaoyu Yang, Shenzhen Huang, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 12
Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions
Katrin Pansy, Barbara Uhl, Jelena Krstić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13311-13311
Open Access | Times Cited: 75
Katrin Pansy, Barbara Uhl, Jelena Krstić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13311-13311
Open Access | Times Cited: 75
KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma
Chen Meng, Yuhang Jiang, Yangbai Sun
Biochemical and Biophysical Research Communications (2021) Vol. 550, pp. 77-83
Closed Access | Times Cited: 68
Chen Meng, Yuhang Jiang, Yangbai Sun
Biochemical and Biophysical Research Communications (2021) Vol. 550, pp. 77-83
Closed Access | Times Cited: 68
